BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peng S, Xiao F, Chen M, Gao H. Tumor-Microenvironment-Responsive Nanomedicine for Enhanced Cancer Immunotherapy. Adv Sci (Weinh) 2022;9:e2103836. [PMID: 34796689 DOI: 10.1002/advs.202103836] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Pan X, Wang C, Liu H. Modulation of reactive oxygen species to enhance sonodynamic therapy. Particuology 2023;75:199-216. [DOI: 10.1016/j.partic.2022.08.001] [Reference Citation Analysis]
2 Guo S, Zhu X, Huang Z, Wei C, Yu J, Zhang L, Feng J, Li M, Li Z. Genomic instability drives tumorigenesis and metastasis and its implications for cancer therapy. Biomedicine & Pharmacotherapy 2023;157:114036. [DOI: 10.1016/j.biopha.2022.114036] [Reference Citation Analysis]
3 Feng Y, Liao Z, Zhang H, Xie X, You F, Liao X, Wu C, Zhang W, Yang H, Liu Y. Emerging nanomedicines strategies focused on tumor microenvironment against cancer recurrence and metastasis. Chemical Engineering Journal 2023;452:139506. [DOI: 10.1016/j.cej.2022.139506] [Reference Citation Analysis]
4 Singh N, Shi S, Goel S. Ultrasmall Silica Nanoparticles in Translational Biomedical Research: Overview and Outlook. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114638] [Reference Citation Analysis]
5 Peng T, Xu T, Liu X. Research progress of the engagement of inorganic nanomaterials in cancer immunotherapy. Drug Deliv 2022;29:1914-32. [PMID: 35748543 DOI: 10.1080/10717544.2022.2086940] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Karizak AZ, Salmasi Z, Gheibihayat SM, Asadi M, Ghasemi Y, Tajbakhsh A, Savardashtaki A. Understanding the regulation of “Don’t Eat-Me” signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy. J Cancer Res Clin Oncol 2022. [DOI: 10.1007/s00432-022-04452-w] [Reference Citation Analysis]
7 Faria P, Pacheco C, Moura RP, Sarmento B, Martins C. Multifunctional nanomedicine strategies to manage brain diseases. Drug Deliv and Transl Res 2022. [DOI: 10.1007/s13346-022-01256-w] [Reference Citation Analysis]
8 Cao J, Liu X, Yuan X, Meng F, Sun X, Xu L, Li H, Liu Y, Hong Z, Bai J. Enzyme-induced morphological transformation of self-assembled peptide nanovehicles potentiates intratumoral aggregation and inhibits tumour immunosuppression. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140466] [Reference Citation Analysis]
9 Tong F, Hu H, Xu Y, Zhou Y, Xie R, Lei T, Du Y, Yang W, He S, Huang Y, Gong T, Gao H. Sensitized photothermal therapy of breast cancer and brain metastases. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.003] [Reference Citation Analysis]
10 Wang F, Pu K, Li J. Activating Nanomedicines with Electromagnetic Energy for Deep‐Tissue Induction of Immunogenic Cell Death in Cancer Immunotherapy. Small Methods 2022. [DOI: 10.1002/smtd.202201083] [Reference Citation Analysis]
11 Wu W, Pu Y, Zhou B, Shen Y, Gao S, Zhou M, Shi J. Photoactivatable Immunostimulatory Nanomedicine for Immunometabolic Cancer Therapy. J Am Chem Soc 2022. [PMID: 36215038 DOI: 10.1021/jacs.2c07872] [Reference Citation Analysis]
12 Wu X, Deng Z, Zhao Q. Immunotherapy improves disease prognosis by affecting the tumor microenvironment: A bibliometric study. Front Immunol 2022;13:967076. [DOI: 10.3389/fimmu.2022.967076] [Reference Citation Analysis]
13 Li Y, Li X, Deng M, Ye C, Peng Y, Lu Y, Liang S. Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m6A Methylation of COL10A1. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/4320809] [Reference Citation Analysis]
14 Jiang Z, Zhang W, Zhang J, Liu T, Xing J, Zhang H, Tang D. Nanomaterial-Based Drug Delivery Systems: A New Weapon for Cancer Immunotherapy. Int J Nanomedicine 2022;17:4677-96. [PMID: 36211025 DOI: 10.2147/IJN.S376216] [Reference Citation Analysis]
15 Shen M, Chen C, Guo Q, Wang Q, Liao J, Wang L, Yu J, Xue M, Duan Y, Zhang J. Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect. Advanced Science. [DOI: 10.1002/advs.202203523] [Reference Citation Analysis]
16 Mukherjee AG, Wanjari UR, Namachivayam A, Murali R, Prabakaran DS, Ganesan R, Renu K, Dey A, Vellingiri B, Ramanathan G, Doss C. GP, Gopalakrishnan AV. Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach. Vaccines 2022;10:1493. [DOI: 10.3390/vaccines10091493] [Reference Citation Analysis]
17 Zhu J, Chang R, Wei B, Fu Y, Chen X, Liu H, Zhou W. Photothermal Nano-Vaccine Promoting Antigen Presentation and Dendritic Cells Infiltration for Enhanced Immunotherapy of Melanoma via Transdermal Microneedles Delivery. Research 2022;2022:1-19. [DOI: 10.34133/2022/9816272] [Reference Citation Analysis]
18 Lu Z, Liu D, Wei P, Yi T. Activated aggregation strategies to construct size‐increasing nanoparticles for cancer therapy. WIREs Nanomed Nanobiotechnol 2022. [DOI: 10.1002/wnan.1848] [Reference Citation Analysis]
19 Bogdanov A, Bogdanov A, Chubenko V, Volkov N, Moiseenko F, Moiseyenko V. Tumor acidity: From hallmark of cancer to target of treatment. Front Oncol 2022;12:979154. [DOI: 10.3389/fonc.2022.979154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Wang Y, Qiu Q, Liao R, Wang X, Zhou Z, Zhang X, Zhang H, He Z, Zhang S, Luo C, Sun J. Modularly engineered prodrug-nanoassemblies for cancer therapy: Nonpharmacological moiety dominating delivery fates. Nano Res . [DOI: 10.1007/s12274-022-4819-z] [Reference Citation Analysis]
21 Sia CS, Lim HP, Tey BT, Goh BH, Low LE. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment. Biochim Biophys Acta Rev Cancer 2022;1877:188779. [PMID: 35977690 DOI: 10.1016/j.bbcan.2022.188779] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Li T, Wang J, Chen T, Wageh S, Al-ghamdi AA, Yu J, Xie Z, Zhang H. A hybrid of lactic acid bacteria and metal-organic frameworks potentiates photodynamic immunotherapy for hypoxia-targeted tumor eradication. Sci China Mater 2022. [DOI: 10.1007/s40843-022-2141-7] [Reference Citation Analysis]
23 Zhao C, Wang Y, Shi B, Li M, Yan W, Yang H. Tailoring co-assembly loading of doxorubicin in solvent-triggering gel. Journal of Colloid and Interface Science 2022. [DOI: 10.1016/j.jcis.2022.06.175] [Reference Citation Analysis]
24 Du Y, Zhang Z, Yang Y, Liu T, Chen T, Li X. Highly active selenium nanotherapeutics combined with metformin to achieve synergistic sensitizing effect on NK cells for osteosarcoma therapy. Nanophotonics 2022;0. [DOI: 10.1515/nanoph-2022-0289] [Reference Citation Analysis]
25 Ling J, Chang Y, Yuan Z, Chen Q, He L, Chen T. Designing Lactate Dehydrogenase-Mimicking SnSe Nanosheets To Reprogram Tumor-Associated Macrophages for Potentiation of Photothermal Immunotherapy. ACS Appl Mater Interfaces 2022;14:27651-65. [PMID: 35675569 DOI: 10.1021/acsami.2c05533] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Shang Q, Dong Y, Su Y, Leslie F, Sun M, Wang F. Local scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy. Adv Drug Deliv Rev 2022;185:114308. [PMID: 35472398 DOI: 10.1016/j.addr.2022.114308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Wei J, Wu D, Shao Y, Guo B, Jiang J, Chen J, Zhang J, Meng F, Zhong Z. ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy. J Control Release 2022:S0168-3659(22)00244-9. [PMID: 35513207 DOI: 10.1016/j.jconrel.2022.04.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
28 Li JH, Huang LJ, Zhou HL, Shan YM, Chen FM, Lehto VP, Xu WJ, Luo LQ, Yu HJ. Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy. Acta Pharmacol Sin 2022. [PMID: 35484402 DOI: 10.1038/s41401-022-00910-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Zhou Y, Liu R, Shevtsov M, Gao H. When imaging meets size-transformable nanosystems. Adv Drug Deliv Rev 2022;183:114176. [PMID: 35227872 DOI: 10.1016/j.addr.2022.114176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zheng C, Zhang W, Wang J, Zhai Y, Xiong F, Cai Y, Gong X, Zhu B, Zhu HH, Wang H, Li Y, Zhang P. Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]